Credit: Shutterstock photoAmerican depositary receipts of European stocks were trading 0.19% lower at 139.85 on the Bank of New York Mellon Europe ADR Index on Tuesday.
In continental Europe, the gainers were led by biopharmaceutical company Biofrontera ( BFRA ), and biotech firm argenx ( ARGX ), which rose 5.6% and 2.8% respectively. They were followed by biopharmaceutical company Forward Pharma ( FWP ), and communications services provider VEON Com ( VEON ), which climbed 1.4% and 1.3%.
The decliners in continental Europe were led by geophysical equipment company CGG ( CGG ), which plunged 26.7%, followed by biopharmaceutical company Cellectis (CLLS), which dropped 2.9%. Telecommunications provider Telecom Italia (TI), and hotel booking site Trivago (TRVG) lost 2.6% and 2.2% respectively.
In the UK and Ireland, the gainers were led by biopharmaceutical firm Amarin (AMRN), and mining company Randgold Resources (GOLD), which increased 2.5% and 1.3% respectively. They were followed by cruise line operator Carnival (CUK), and mining company Rio Tinto (RIO), which were up 1.1% and 0.6%.
The decliners in the UK and Ireland were led by biopharmaceutical firm NuCana (NCNA), and gene therapy company Nightstar (NITE), which fell 4.9% and 5.1% respectively. They were followed by pharmaceutical company Avadel (AVDL), and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which dropped 5% and 2.4%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
